Therefore, identifying prognostic markers might be significant for reducing CRC mortality and thus improving treatment.
← all excerpts
The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
1
—
—